Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase IIa proof of concept study of ADX71149 in Epilepsy.

Next Previous
Trial Profile

A Phase IIa proof of concept study of ADX71149 in Epilepsy.

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Feb 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs ADX 71149 (Primary) ; Levetiracetam (Primary)
  • Indications Epilepsy
  • Focus Proof of concept; Therapeutic Use

    • Most Recent Events

    • 06 Feb 2023 Status changed from planning to recruiting.
    • 06 Feb 2023 According to Addex Therapeutics media release, based on the outcome of this review and recommendations from the IRC, Janssen will evaluate the next steps for the program around the quarter end of 2023.
    • 06 Feb 2023 According to Addex Therapeutics media release, data from part I will be evaluated by an independent interm review committee (IRC) to ensure the study remains blinded.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top